Sponsored By

FDA’s new CBD report is a recipe for Congressional action

Regulatory agency is intent on slow-walking the process to formally approve hemp CBD products

Todd Runestad

March 11, 2020

5 Min Read
Congress-FDA-cbd-regulation.png
The Hemp Roundtable is calling for Congress to co-sponsor H.R. 5587, which would allow FDA-regulated, hemp-derived CBD to be marketed in supplements and as food and beverage additives.MysteryShot/iStock/Getty Images Plus

Create a free account or login

This content is available for registered users. Subscribe now to access this article.

Stay up-to-date on the latest food retail news and trends
Subscribe to free eNewsletters from Supermarket News